Results per Page:
The Beam: New superhero comic book for proton therapy patients; our physicians present at ASTRO; meet our new brain cancer specialist
The Proton Pro-Team comic; latest in radiation oncology; meet Dr. Lisa Ni
Benign meningiomas can’t stop YAP-ing, but aggressive subtypes are more soft-spoken
From the Holland Lab, Human Biology Division
A look at four lives: what life is like years after proton therapy
Four patients share their experience and advice
New technique could help make precision medicine more widely available
Simple CUT&Tag adaptation gives information about genetic regulatory elements in formalin-fixed tumor samples
First Lady Jill Biden: ‘Your work will change and save lives’
MET-X research lab tour and Cancer Moonshot ‘listening session’ on survivorship and pediatric cancer highlight First Lady's visit to Fred Hutch
Brain cancer expert Dr. Eric Holland receives Endowed Chair in Cancer Biology
Chair recognizes comprehensive vision, contributions to solid tumor research
Introducing the Brain-UMAP: a reference map of the human brain
From the Holland lab, Human Biology Division
Melding data creates wider landscape of brain cancer
New computational visualization tool allows researchers to compare different tumor types, normal brain tissue, pinpoint cancer-promoting alterations
Innovative Holland Lab mouse model helps tease apart YAP1’s role in brain cancer
From the Holland Lab, Cancer Basic Biology Program, Cancer Consortium.
Holland receives NCI Outstanding Investigator Award
Neuroscientist will tackle genetic abnormalities that drive cancers and could be therapeutic targets
Gabe's Story: childhood cancer survivor becomes a race car driver
Diagnosed with brain cancer at age 11, this teen now has big dreams for the road ahead
New study shows cancer-causing ‘Frankengene’ mutation could be target for new drugs
This gene is fused to many partner genes in different tumors. Now, scientists know it causes cancer — and how they might intervene
Fred Hutch–led team receives $6M to study deadly brain tumor
Researchers seek deeper understanding of ependymoma biology to aid treatment discovery
Brain cancer subtype caused by single gene fusion
Hutch researchers create genetically relevant model to examine the biology of supratentorial ependymomas
Nanoparticles take immunotherapy in new direction
Hutch scientist to use nanoparticles to reprogram macrophages to tackle brain tumors
Study sheds light on why brain cancers become aggressive and treatment-resistant
New computational method sheds light on how cancer-contributing genes make brain tumors more aggressive and radiation-resistant